Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2024) 213 (10): 1403.

PILLARS OF IMMUNOLOGY

J Immunol (2024) 213 (10): 1405–1406.

BRIEF REVIEWS

J Immunol (2024) 213 (10): 1407–1413.

AUTOIMMUNITY

J Immunol (2024) 213 (10): 1415–1428.

  • Overexpression of IFIH1946T resulted in an elevated level of basal type I IFN signaling and increased basal ISG expression.

  • Recombinant MDA5 with the rs1990760 SNP (A946T) had increased ATPase activity in vitro.

J Immunol (2024) 213 (10): 1429–1440.

  • LANCL2 activation induces anti-inflammatory effects in CD4+ T cells and phagocytes.

  • NIM-1324 activates LANCL2 to reduce proteinuria and disease severity in SLE models.

  • NIM-1324 reduces type I IFN and inflammatory cytokines in human PBMCs.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2024) 213 (10): 1441–1451.

  • Distinct T cell changes may predict AML relapse post-HSCT.

  • Machine learning may predict AML relapse before disease reoccurrence.

J Immunol (2024) 213 (10): 1452–1466.

  • In MIS-C, monocytes were hyperactive for phagocytosis and cytokine production.

  • In MIS-C, NK cells were hypoactive for ADCC, and their function inversely correlated with systemic IL-6.

  • High affinity anti-CD16 Trispecific reagents were able to rescue NK activity and target SARS-CoV-2.

IMMUNE REGULATION

J Immunol (2024) 213 (10): 1467–1478.

  • MARCH8 mediates K27-linked polyubiquitination at K265/K266 and degradation of IL-7Rα.

  • ΜΑRCH8 deficiency enhances IL-7–triggered CD8+ T cell expansion and differentiation.

IMMUNE SYSTEM DEVELOPMENT

J Immunol (2024) 213 (10): 1479–1487.

  • Maternal vitamin D status regulates fetal hematopoiesis and the adult immune system.

  • Developmental vitamin D deficiency resulted in fewer Vdr+ adult immune cells.

  • Functional effects of vitamin D deficiency include impaired response to infection.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2024) 213 (10): 1488–1498.

  • There is a transient increase in Tim-3+ Tregs during chronic LCMV infection.

  • Tim-3+ Tregs promote dysfunction of CD8+ T cells during chronic infection with LCMV.

  • Treg-specific Tim-3 deficiency promotes clearance of chronic LCMV infection.

J Immunol (2024) 213 (10): 1499–1507.

  • S1P produced by SphK1 guides immune cell trafficking and activation.

  • SphK-S1P signaling altered in HBV-infected patients.

  • HBV manipulates SphK1 expression through transcription factor USF1.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2024) 213 (10): 1508–1515.

  • We describe a novel reporter mouse with mScarlet-I knocked in to the Fth1 locus.

  • High Fth1-mScarlet is restricted to alveolar macrophages in the steady-state lung.

  • Fth1-mScarlet reports monocyte-to-macrophage differentiation in lung inflammation.

MUCOSAL IMMUNOLOGY

J Immunol (2024) 213 (10): 1516–1527.

  • IgA and IgG were abundant in the FGT and demonstrated ex vivo binding to vaginal bacteria.

  • Total and microbe-binding IgA and IgG correlate with reduced bacterial abundance in the FGT.

  • Likewise, IgA and IgG correlate with increased proinflammatory cytokines and chemokines.

SYSTEMS IMMUNOLOGY

J Immunol (2024) 213 (10): 1528–1541.

  • In vivo CRISPR screening identifies novel epigenetic regulators of CD8+ T cells.

  • The chromatin remodeler CHD7 is a positive regulator of SLEC formation.

TRANSPLANTATION

J Immunol (2024) 213 (10): 1542–1552.

  • Interruption of the CXCR4–CXCL12 axis diminished cell infiltration in aortic allograft.

  • Plerixafor reduced aortic luminal occlusion on day 30 after transplantation.

  • Pulsed plerixafor therapy attenuates chronic rejection in a mouse transplant model.

TUMOR IMMUNOLOGY

J Immunol (2024) 213 (10): 1553–1568.

  • Ly6Chi monocytes express high α5β1 and migrate via elevated CCR2 expression.

  • F4/80+αv+ macrophages in the tumor are protumorigenic and show an M2 TAM phenotype.

  • FAK signaling is associated with integrin α5 and αv–mediated TAM polarization in vitro.

CORRECTIONS

J Immunol (2024) 213 (10): 1569.
Close Modal

or Create an Account

Close Modal
Close Modal